|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 53.25 EUR | -0.09% |
|
+0.57% | +5.24% |
| 03-19 | Italy - Factors to watch on March 19 | RE |
| 03-18 | Recordati Proposes Dividend Of EUR 1.27 Per Share | RE |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last hours
Enjoy this offer
* See conditions on site
| Capitalization | 10.9B 11.86B 10.44B 9.14B 17B 1,024B 18.73B 120B 45.68B 447B 44.5B 43.58B 1,778B | P/E ratio 2024 * |
25.2x | P/E ratio 2025 * | 22.2x |
|---|---|---|---|---|---|
| Enterprise value | 12.8B 13.93B 12.25B 10.74B 19.96B 1,202B 21.99B 141B 53.63B 525B 52.25B 51.16B 2,088B | EV / Sales 2024 |
5.34x | EV / Sales 2025 * | 4.83x |
| Free-Float |
46.81% | Yield 2024 * |
2.58% | Yield 2025 * | 2.84% |
More valuation ratios
* Estimated data
| Italy - Factors to watch on March 19 | 03-19 | RE |
| Recordati Proposes Dividend Of EUR 1.27 Per Share | 03-18 | RE |
| DIARY - Italy to April 30 | 03-18 | RE |
| Italy - Factors to watch on March 18 | 03-18 | RE |
| RBC Bullish on Recordati's Growth Potential Ahead of Updated Three-year Plan | 03-14 | MT |
| DIARY - Italy to April 30 | 03-14 | RE |
| Europeans expected in green; focus on tariffs clash | 03-12 | AN |
| Only six stocks in green on the Mib; U.S. duties weigh. | 03-11 | AN |
| DIARY - Italy to April 30 | 03-11 | RE |
| DIARY - Italy to April 30 | 03-07 | RE |
| DIARY - Italy to April 30 | 03-04 | RE |
| DIARY - Italy to April 30 | 02-28 | RE |
| DIARY - Italy to March 31 | 02-25 | RE |
Last Transcript: Recordati
More press releases
More news
| 1 day | +0.09% | ||
| 1 week | +0.76% | ||
| Current month | -1.75% | ||
| 1 month | -2.73% | ||
| 3 months | +5.85% | ||
| 6 months | +6.83% | ||
| Current year | +5.43% |
1 week
52.3
53.95
1 month
52.15
55.05
Current year
50.65
60.95
1 year
47.28
60.95
3 years
34.52
60.95
5 years
33.04
60.95
10 years
16.41
60.95
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Koremans
CEO | Chief Executive Officer | 62 | 30/11/2021 |
Luigi la Corte
DFI | Director of Finance/CFO | 55 | 31/10/2019 |
Raffaele Sabia
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrea Recordati
CHM | Chairman | 53 | 30/11/2021 |
| Director/Board Member | 54 | 16/04/2014 | |
Giampiero Mazza
CHM | Chairman | 55 | 11/06/2018 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.09% | +0.76% | +4.90% | +16.69% | 11.86B | ||
| +1.76% | +1.84% | +8.31% | +190.99% | 752B | ||
| -0.77% | +0.09% | +4.34% | -6.78% | 393B | ||
| -0.75% | +0.09% | +18.14% | +33.32% | 375B | ||
| -0.70% | +2.34% | -40.43% | +44.05% | 354B | ||
| +0.34% | +1.12% | +32.71% | -16.52% | 279B | ||
| -0.74% | +0.72% | -23.06% | +18.85% | 237B | ||
| +0.36% | -0.66% | +16.14% | +22.59% | 237B | ||
| +0.91% | +2.28% | +16.48% | +23.00% | 221B | ||
| -0.91% | +1.04% | +16.20% | +33.65% | 170B | ||
| Average | +0.18% | +1.47% | +5.37% | +35.98% | 302.86B | |
| Weighted average by Cap. | +0.46% | +1.68% | +4.74% | +61.15% |
| 2024 | 2025 * | |
|---|---|---|
| Net sales | 2.32B 2.53B 2.22B 1.95B 3.62B 218B 3.99B 25.57B 9.73B 95.26B 9.48B 9.28B 379B | 2.62B 2.85B 2.51B 2.2B 4.09B 246B 4.5B 28.85B 10.98B 107B 10.7B 10.48B 428B |
| Net income | 465M 506M 445M 390M 725M 43.71B 799M 5.12B 1.95B 19.08B 1.9B 1.86B 75.9B | 504M 549M 483M 423M 787M 47.41B 867M 5.55B 2.11B 20.7B 2.06B 2.02B 82.32B |
| Net Debt | 1.9B 2.07B 1.82B 1.59B 2.96B 178B 3.26B 20.89B 7.95B 77.85B 7.75B 7.59B 310B | 1.75B 1.9B 1.67B 1.47B 2.73B 164B 3.01B 19.26B 7.33B 71.76B 7.14B 6.99B 285B |
More financial data
* Estimated data
Employees
4,455
Sector
Pharmaceuticals
Calendar
04-28
- Annual General Meeting
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/03/25 | 53.25 € | -0.09% | 113,751 |
| 19/03/25 | 53.30 € | -0.28% | 402,642 |
| 18/03/25 | 53.45 € | +0.19% | 409,945 |
| 17/03/25 | 53.35 € | +1.23% | 338,836 |
| 14/03/25 | 52.70 € | -0.47% | 307,523 |
Real-time Borsa Italiana, March 20, 2025 at 08:47 am
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
53.30EUR
Average target price
58.39EUR
Spread / Average Target
+9.55%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- REC Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition